ACB ▼ -1.3% - Aurora Cannabis Inc. $ACB ACB ACB - Aurora Appoints Seasoned Biopharmaceutical Executive to Lead Commercial Acceleration of Global Medical Cannabis Business Aurora Cannabis appointed a biopharmaceutical executive to lead commercial acceleration of its global medical cannabis business, a strategic move aimed at strengthening its medical division operations. The stock declined 1.3% today, suggesting investors may have been concerned about execution challenges or questions about the timing of this leadership change. 09-SEP-2026 07:06 AM ET